Recordati Industria Chimica e Farmaceutica SpA Announces Three-Year Growth Plan
Recordati Industria Chimica e Farmaceutica SpA, an Italian pharmaceutical company, has outlined a three-year plan for the period 2025-2027. The plan aims to drive organic growth of the company’s current product portfolio through strategic business development and mergers & acquisitions.
Key objectives of the plan include:
- Driving organic growth of the current product portfolio
- Pursuing strategic business development and mergers & acquisitions
- Maintaining sector-leading margins through a diversified business model
The company forecasts double-digit growth for the fiscal year 2027, building on its positive momentum. In response to market volatility and tariffs, Recordati is actively seeking acquisition opportunities, viewing the current market conditions as favorable for deal-making.